Erschienen in:
07.07.2017 | Original Article
CD34-negative hematopoietic stem cells show distinct expression profiles of homing molecules that limit engraftment in mice and sheep
verfasst von:
Tomoyuki Abe, Yoshikazu Matsuoka, Yoshikazu Nagao, Yoshiaki Sonoda, Yutaka Hanazono
Erschienen in:
International Journal of Hematology
|
Ausgabe 5/2017
Einloggen, um Zugang zu erhalten
Abstract
We and others have reported that human hematopoietic stem cells (HSCs) are also present in the CD34-negative (CD34−) fraction of human cord blood (CB). Here, we examined the hematopoietic engraftment potential of 13 or 18 lineage-negative (13Lin− or 18Lin−) CD34+/− cells from human CB in mice and sheep. Both 13Lin− and 18Lin− CD34+ cells efficiently engrafted in mice irrespective of transplantation route, be it by tail-vein injection (TVI) or by intra-bone marrow injection (IBMI). These cells also engrafted in sheep after in utero fetal intra-hepatic injection (IHI). In contrast, neither 13Lin− nor 18Lin− CD34− cells engrafted in either mice or sheep when transplanted by regular routes (i.e., TVI and fetal IHI, respectively), although both 13Lin− and 18Lin− CD34− cells engrafted in mice when transplanted by IBMI and exhibited multilineage reconstitution ability. Thus, the homing ability of CD34− HSCs is significantly more limited than that of CD34+ HSCs. As for 18Lin−, CD34− HSCs are characterized by low expression of the tetraspanin CD9, which promotes homing, and high expression of the peptidase CD26, which inhibits homing. This unique expression pattern homing-related molecules on CD34− HSCs could thus explain in part their reduced ability to home to the BM niche.